Events
-
ENDO 2026: Women’s thyroid cancer risk may be linked to reproductive lifespan and hormone therapy
-
ASCO 2026: Lancet Commission predict shortfall of 100 million cancer care workers by 2050
-
ASCO 2026: CAPTURE trial delivers learnings for metastatic breast cancer treatment
-
ASCO 2026: Teclistamab extends survival, deepens remissions in relapsed multiple myeloma
-
ASCO 2026: Lancet Commission predict shortfall of 100 million cancer care workers by 2050
-
-
ASCO 2026: Teclistamab extends survival, deepens remissions in relapsed multiple myeloma
-
-
-
Sweet new technology: Reveals more about T Cell killers of cancer
Peter Mac researchers have developed a new sugar-sensing single cell sequencing technology, which has allowed…
Melanoma patients respond to immunotherapy after changes to gut microbiome
Statistical modeling developed by Oregon State University, USA, has confirmed that changes to melanoma patients’…
COVID-19 and Telehealth: Practical guide for cancer clinicians
Australian cancer clinicians welcome a new resource to guide them through changes in practice brought…
Exploring CAR T-cell therapy to treat breast cancer
- BGICC consensus and recommendations for the management of triple-negative breast cancer
- A connection between senescence and stem cells caused by a breast cancer-initiating protein
- Researchers discover a path that transforms ER /HER2 breast cancer into a fast-growing metastatic ER-/HER2 type breast cancer
Confusion over symptoms may be affecting whether women take tamoxifen for breast cancer
Women who are at high risk of developing breast cancer may be failing to take the preventive anti-cancer drug tamoxifen…
JOIN THE ONCOLOGY NETWORK
If you would like even more free news articles, access to our exclusive HCP only content including the latest podcasts from The Oncology Podcast and our Industry Partner Podcasts (including links to all papers and show notes), along with all our other resources, head over to The Oncology Network and sign up - FREE forever for HCPs only.